Injectable cosmetic use should not be presented as routine, proven or risk free
However, as with all adjunct interventions during GLP-1 therapy, this should be evaluated and supervised by a qualified physician
It became the first peptide therapy and has been used continuously for over 100 years
On the general safety profiles of ICI agents, a head-to-head comparison of 36 phase 1 and phase 2 clinical trials that enrolled 15,370 patients found that the safety ranking of ICIs as follows: Atezolizumab (pooled incidence 66.4%, probability 76%), Nivolumab (71.8%, 56%), Pembrolizumab (75.1%, 55%), Ipilimumab (86.8%, 55%) and Tremelimumab (not applicable (NA), 54%)
The highly absorbable form that supports oxygen transport
When these chemical signals are balanced and firing correctly, digestion is a seamless, unconscious process